Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2909-01 Phase I Study in Healthy Volunteers and Patients with Narcolepsy
jRCT2071200073Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ONO-2909 in narcolepsy (11 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Safety and tolerability of ONO-2909 (all parts), Pharmacokinetics of ONO-2909 (all parts) and 2 more. Started Jan 2021; status: completed.
02
Drugs
ONO-2909
03
Conditions
narcolepsy
Beyond the preview
Go deeper on jRCT2071200073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200073.